Cisplatin and Bell's palsy - a phase IV clinical study of FDA data

Summary:

Bell's palsy is reported as a side effect among people who take Cisplatin (cisplatin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Cytarabine, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Bell's palsy when taking Cisplatin. It is created by eHealthMe based on reports of 92,672 people who have side effects when taking Cisplatin from the FDA, and is updated regularly.

What is Cisplatin?

Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.

What is Bell's palsy?

Bell's palsy (facial paralysis) is found to be associated with 569 drugs and 1,255 conditions by eHealthMe. Check the latest studies of Bell's palsy.

On Jul, 06, 2026

92,672 people reported to have side effects when taking Cisplatin.
Among them, 35 people (0.04%) have Bell's palsy.

Among these 35 people:

How long have people been on Cisplatin when they have Bell's palsy? *

What is the gender of people who have Bell's palsy when taking Cisplatin? *

female: 17.65 %
male: 82.35 %

What is the age of people who have Bell's palsy when taking Cisplatin? *

What are other drugs people take besides Cisplatin? *

What are other side effects people have besides Bell's palsy? *

Diplopia (double vision): 8 people, 22.86%
Speech Impairment (Adult) (inability to speak (adult)): 7 people, 20.00%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 7 people, 20.00%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 7 people, 20.00%
Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 6 people, 17.14%
Hemiparesis (weakness on one side of the body): 4 people, 11.43%
Fever: 4 people, 11.43%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 4 people, 11.43%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 8.57%
Hypokalemia (low potassium): 3 people, 8.57%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 9 people, 25.71%
Mesothelioma Malignant (cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 2 people, 5.71%
Bone Neoplasm Malignant (cancer of bone): 2 people, 5.71%
Testis Cancer (testes cancer): 1 person, 2.86%
Testicular Germ Cell Cancer (germ cell cancer of testes): 1 person, 2.86%
Otitis Media (inflammation of the middle ear): 1 person, 2.86%
Oesophageal Cancer Metastatic (cancer of oesophagues spreads to other part): 1 person, 2.86%
Nausea (feeling of having an urge to vomit): 1 person, 2.86%
Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 1 person, 2.86%
Germ Cell Cancer: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Cisplatin and have Bell's palsy?

- Check whether Bell's palsy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cisplatin:

Cisplatin (92,837 reports)

Bell's palsy treatments and more:

Bell's palsy (7,037 reports)

Browse all side effects of Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bell's palsy:

Bell's palsy (569 drugs)

Browse all the conditions that are associated with Bell's palsy:

Bell's palsy (1,255 conditions)

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cisplatin (the active ingredients of Cisplatin) and Cisplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.